Generics - Rest of the World, Asia-Pacific


Popular Filters

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar


USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal


The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Indian drugmakers show interest in investing in Zimbabwe


Owen Mugurungi, director of the Aids and TB Unit in Zimbabwe's Ministry of Health Child and Welfare,…

Anti-viralsAsia-PacificGenericsProductionRest of the World

Natco in biogenerics in deal with Mabxience; plans generic launches in South Africa


Hyderabad, India-based generic drugmaker Natco Pharma (524816: BY) has entered into an exclusive agreement…

Asia-PacificbevacizumabBiotechnologyetanerceptGenericsLicensingMabxienceMarkets & MarketingNatco PharmaRest of the Worldrituximabtrastuzumab

Second Indian generics deal for SA’s Litha, this one with Micro Labs


In a second deal with an Indian drugmaker, South Africa’s Litha Healthcare has signed an exclusive…

Asia-PacificGenericsLicensingLitha HealthcareRest of the World

Back to top